Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
Search
:::

張景智 (Ching Chih Chang)

張景智(Ching Chih Chang)圖 Return Appointment First Appointment

[Profile]

  • Education
    • M.D., Yang-Ming Medical University,
  • Career and Experience
    Current Positions：
    • - Now, Chief of Holistic and Multidisciplinary Medicine,
    • - Now, Attending Physician of Internal Medicine.,
    • - Now, Attendig Physician, Division of Gastroenterology, Guan-Du Hospital,
    • - Now, Attending Physician, Division of General Medicine, Taipei Veterans General Hospital,
    • - Now, Associate Professor of medicine, Faculty of medicine, National Yang-Ming Medical University,
    Experiences：
  • Medical Expertise
    1. General internal medicine、hepatitis and liver cirrhosis with complications 、gastroenterological disease
  • License
    License of physician, Taiwan, Specialist of internal physician, Specialist ofgastroenterology, Specialist of endoscopist , Specialist of ultrasound

[Publications]

PUBLICATIONS：

  1. Huang HC, Hsu SJ, Chang CC, Chuang CL, Hou MC, Lee FY. Effects of PCSK-9 Inhibition by Alirocumab Treatments on Biliary Cirrhotic Rats. Int J Mol Sci. 2022 Jul 2;23(13):7378. IF=5.924 (Biochemistry, molecular biology; R/C=67/295, 23%)通訊作者
  2. Hsu SJ, Huang HC, Chuang CL, Chang CC, Hou MC, Lee FY, Lee SD. Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats. Pharmaceutics. 2020 Apr 2;12(4):E320. IF=6.321 (Pharmacology and pharmacy, R/C 26/267, 11%)通訊作者
  3. Chang T, Ho HL, Hsu SJ, Chang CC, Tsai MH, Huo TI, Huang HC, Lee FY, Hou MC, Lee SD. Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats. Int J Mol Sci. 2019 Aug 26;20(17). IF=5.924 (Biochemistry, molecular biology; R/C=67/295, 23%) 通訊作者
  4. Chang CC, Chuang CL, Tsai MH, Hsin IF, Hsu SJ, Huang HC, Lee FY, Lee SD. Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats. Int J Mol Sci. 2019 Mar 28;20(7). IF=5.924 (Biochemistry, molecular biology; R/C=67/295, 23%) 第一作者
  5. Wu KC, Huang HC, Chang T, Lee WS, Chuang CL, Hsin IF, Hsu SJ, Lee FY, Chang CC, Lee SD.Effect of sirolimus on liver cirrhosis and hepatic encephalopathy of common bile duct-ligated rats. Eur J Pharmacol. 2018 Apr 5;824:133-139. IF=4.432 (Pharmocology and Pharmacy, Research & Experiment; R/C=86/276, 31%)通訊作者
回到最上